We carried out financial and tax due diligence for Baird Capital in relation to its investment in Prescient Healthcare Group.
Prescient is a product strategy consultancy to the global biopharmaceutical industry. Founded in 2007, Prescient is headquartered in London and has offices in the US, India and China. Baird’s investment and global resources are expected to help further accelerate Prescient’s growth.
“BDO did an excellent job supporting Baird Capital on this transaction. Andrew and the team effectively navigated the complexities of a global healthcare consulting business with various service lines and a multi-currency revenue model without missing a deadline. The BDO team demonstrated a professional, highly responsive, and consultative approach enabling them to add strategic insights to Baird's evaluation of this opportunity. We look forward to working with Andrew and the BDO team again.”
John DiGiovanni, Principal - Baird Capital